INTERNATIONAL PATENT: ATOSSA THERAPEUTICS, INC. FILES APPLICATION FOR "ENDOXIFEN FOR TREATING DUCHENNE MUSCULAR DYSTROPHY"

GENEVA, Oct. 6 -- ATOSSA THERAPEUTICS, INC. (10202 5th Avenue NE, Suite 200Seattle, Washington 98125) filed a patent application (PCT/US2025/021347) for "ENDOXIFEN FOR TREATING DUCHENNE MUSCULAR DYSTROPHY" on Mar 25, 2025. With publication no. WO/2025/207636, the details related to the patent application was published on Oct 02, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): QUAY, Steven Carl (c/o ATOSSA THERAPEUTICS, INC.10202 5th Avenue NE, Suite 200Seattle, Washington 98125), REMMEL, Harmon Lawrence (c/o ATOSSA THERAPEUTICS, INC.10202 5th Avenue NE, Suite 200Seattle, Washington 98125)

A...